According to Theravance Biopharma 's latest financial reports and stock price the company's current number of shares outstanding is 52,361,000. At the end of 2023 the company had 52,361,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 52.36 M | -22.31% |
2022 | 67.39 M | -8.88% |
2021 | 73.96 M | 16.06% |
2020 | 63.72 M | 13.59% |
2019 | 56.1 M | 2.84% |
2018 | 54.55 M | 3.11% |
2017 | 52.9 M | 6.73% |
2016 | 49.57 M | 47.14% |
2015 | 33.68 M | 6% |
2014 | 31.78 M | -1.48% |
2013 | 32.26 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Corcept Therapeutics
CORT | 102,014,000 | 94.83% | ๐บ๐ธ USA |
Collegium Pharmaceutical
COLL | 33,744,209 | -35.55% | ๐บ๐ธ USA |
Catalyst Pharmaceuticals CPRX | 106,568,137 | 103.53% | ๐บ๐ธ USA |
Catalent CTLT | 182,000,000 | 247.59% | ๐บ๐ธ USA |